CSIMarket Company Name, Ticker, Competitors, else..
 
Akebia Therapeutics Inc   (NASDAQ: AKBA)
 

Akebia Therapeutics Inc's Suppliers Performance

AKBA's Supply Chain



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

 
AKBA Costs vs Sales of Suppliers Growth Akebia Therapeutics Inc recorded an increase in cost of sales by 5.09 % year on year, relative to one quarter ago cost of sales fell by -15.18 % in Q2.

• More on AKBA Suppliers



Akebia Therapeutics Inc recorded increase in cost of sales by 5.09 % year on year, compare to one quarter ago cost of sales fell by -15.18 % in Q2.

• More on AKBA Suppliers




Akebia Therapeutics Inc's Comment on Supply Chain


Auryxia's active pharmaceutical ingredient, ferric citrate, is synthesized at commercial scale from starting materials sourced from multiple suppliers. The company has established relationships with contract manufacturing organizations (CMOs) to support supply for commercial sales and clinical trials. Currently, the manufacture of Auryxia's drug substance and drug product relies on single-source suppliers. The drug substance is supplied by Siegfried Evionnaz SA under a supply agreement featuring per-kilogram pricing and minimum purchase requirements, though the agreement is not exclusive. The drug product is supplied by Patheon Manufacturing Services LLC (Thermo Fisher) under a Master Manufacturing Service Agreement with tiered per-bottle pricing that decreases as volume increases.

Akebia Therapeutics Inc's Comment on Supply Chain


Auryxia's active pharmaceutical ingredient, ferric citrate, is synthesized at commercial scale from starting materials sourced from multiple suppliers. The company has established relationships with contract manufacturing organizations (CMOs) to support supply for commercial sales and clinical trials. Currently, the manufacture of Auryxia's drug substance and drug product relies on single-source suppliers. The drug substance is supplied by Siegfried Evionnaz SA under a supply agreement featuring per-kilogram pricing and minimum purchase requirements, though the agreement is not exclusive. The drug product is supplied by Patheon Manufacturing Services LLC (Thermo Fisher) under a Master Manufacturing Service Agreement with tiered per-bottle pricing that decreases as volume increases.







AKBA's vs. Suppliers, Data

(Revenue and Income for Trailing 12 Months, in Millions of $, except Employees)



COMPANY NAME MARKET CAP REVENUES INCOME EMPLOYEES
Akebia Therapeutics Inc 249.38 219.06 -29.67 194
SUBTOTAL 0.00 0.00 0.00 -


Sources: Akebia Therapeutics Inc 's official press releases and regulatory filings; CSIMarket.com's supply-chain research; and the financial filings and press releases of other companies cited in this report.
Updated on:
For your research, we’ve provided nine additional tables on Akebia Therapeutics Inc ’s suppliers.
You can find them in the navigation menu under Suppliers.
To download the tables, please subscribe.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.